
REG™ is commercializing industrial biotechnology processes that provide cost-competitive, renewable alternatives to petroleum-based chemicals, fuels, and other products to our customers. At the core of our technology are biological catalysts engineered to selectively convert abundant, renewable feedstocks directly to drop-in, advantaged and innovative products. REG™ services include working with partners to provide research and development for new product platforms.
Learn more about our products
REG Life Sciences™
Industry-leading research
- REG Life Sciences™ services include a proprietary method for the synthesis of mid-to-long chain (8 to 18 carbon) chemicals; developed in our R&D laboratories in South San Francisco, California
- Demonstrated expertise with biotechnology tools to optimize molecular composition to customer needs -- for instance, multi-functional chemicals with tailored positioned hydroxyl groups
- Patented process covers the catalytic capabilities of microbial metabolism to produce targeted final products in an environmentally friendly fermentation process
Production capacity
- REG Life Sciences™ services include a demonstration-scale fermentation facility located in Florida with capacity for modifying more than 200 tons/year
- Proprietary technology enables the production of multiple products in our fermentation facility
Diverse feedstock, low-GHG impact
- The REG platform technology can use a variety of feedstocks to produce low-GHG performance molecules and replacements for palm-sourced oleochemicals
- Our process allows us to use low-cost feedstocks to produce sustainable, competively-priced REG chemicals. Calculated low-carbon impact of glycerol feedstock for detergent alcohols is 85 percent lower than incumbent products
Innovate with REG Life Sciences™ Manufacturing Services and R&D Services.
Get creative. Design your next innovative compound with REG Life Sciences.
Explore the capabilities of our biochemical platform by emailing us directly at innovate@regi.com
Catalyst Platform
- Proprietary "oleaginous" E. coli
- Optimized strains: product titers of 150 g/L +
Bio-Chemical Platform
- Combinatorial biochemical pathways to ~15,000 potential products
- Fragrances & flavors, C8/C10 platform, polymer, precursors, novel intermediates
Process Platform
- Biphasic fermentation facilitates separation
- Greater than 100MT capacity facility
Feedstock Flexibility
- Lower-cost glycerol, sugars, and carbohydrates
- Lower lifecycle-GHG compared to conventional chemicals
World-Class Partnerships